Stock BRM BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bristol-Myers Squibb Company Xetra

Equities

BRM

US1101221083

Market Closed - Xetra
Other stock markets
 16:35:43 20/06/2024 BST 		Pre-market 07:01:34
38.02 EUR -0.60% Intraday chart for Bristol-Myers Squibb Company 38.3 +0.71%
06-19 Bristol Myers: ex-CEO of Agilent joins Board of Directors CF
06-18 Bristol Myers Squibb Appoints Michael R. McMullen as Independent Director and Member of the Audit Committee, Effective July 1, 2024 CI

Chart calendar Bristol-Myers Squibb Company

21cb96d1c3cc3784361c3b437f2.mhzMR8a1KbwxU4W8ssDDxZ_q1388MvSOHfLDzAIXQ00.8in9MLXEXs1wEufb2ZW1q8CdoiBbd5rfV7Gmg0h5MyD_UI1_keNRjUg-1A~b8be149cff0a0d54052b166aaa562c07

Upcoming events on Bristol-Myers Squibb Company

26/07/2024 11:59 Q2 2024 Earnings Release
26/07/2024 13:00 Q2 2024 Earnings Call
31/10/2024 10:59 Q3 2024 Earnings Release
31/10/2024 12:00 Q3 2024 Earnings Call
06/02/2025 11:59 Q4 2024 Earnings Release
06/02/2025 13:00 Q4 2024 Earnings Call
24/04/2025 11:59 Q1 2025 Earnings Release
24/04/2025 13:00 Q1 2025 Earnings Call
31/07/2025 11:59 Q2 2025 Earnings Release
31/07/2025 13:00 Q2 2025 Earnings Call
30/10/2025 10:59 Q3 2025 Earnings Release
30/10/2025 12:00 Q3 2025 Earnings Call
28/01/2026 Q4 2025 Earnings Release (Projected)
22/04/2026 Q1 2026 Earnings Release (Projected)
22/07/2026 Q2 2026 Earnings Release (Projected)

Past events on Bristol-Myers Squibb Company

16/06/2024 11:30 European Hematology Association Meeting - Abstract No #S272
16/06/2024 11:30 European Hematology Association Meeting - Abstract No #S158
16/06/2024 04:30 European Hematology Association Meeting - Abstract No #S208
15/06/2024 16:30 European Hematology Association Meeting - Abstract No #S141
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P1522
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P1516
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P1126
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P1132
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P1020
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P1034
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P749
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P780
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P785
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P763
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P774
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P789
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P782
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P768
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P939
14/06/2024 18:00 European Hematology Association Meeting - Abstract No #P903

Past dividends on Bristol-Myers Squibb Company

03/04/2024 Quarterly 0.6 USD
03/01/2024 Quarterly 0.6 USD
04/10/2023 Quarterly 0.57 USD
05/07/2023 Quarterly 0.57 USD
05/04/2023 Quarterly 0.57 USD
04/01/2023 Quarterly 0.57 USD
05/10/2022 Quarterly 0.54 USD
29/06/2022 Quarterly 0.54 USD
30/03/2022 Quarterly 0.54 USD
05/01/2022 Quarterly 0.54 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		26 145
26 418
-1.03%		42 518
42 189
0.78%		46 385
46 366
0.04%		46 159
45 911
0.54%		45 006
44 731
0.62%
46 088

EBITDA
Million USD		Released
Forecast
Spread 		9 945
9 754
1.96%		18 118
20 279
-10.65%		20 493
21 878
-6.33%		20 123
20 368
-1.2%		17 498
18 255
-4.15%
5 170

EBIT
Million USD		Released
Forecast
Spread 		8 199
8 540
-3.99%		17 426
17 664
-1.35%		19 830
19 963
-0.67%		19 442
18 924
2.73%		16 785
16 921
-0.8%
4 017

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		4 975
0,00
- 		-6 871
1 541
-545.88%		8 098
7 644
5.94%		7 713
7 912
-2.51%		8 440
8 846
-4.59%
-5 696

Net income
Million USD		Released
Forecast
Spread 		3 439
0,00
- 		-9 015
1 269
-810.58%		6 994
6 219
12.46%		6 327
6 617
-4.39%		8 025
7 823
2.58%
-5 414

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-3,99
0,53
-851.84%		3,12
2,78
12.07%		2,95
2,97
-0.55%		3,86
3,73
3.53%
-2,63

Announcement Date06/02/2004/02/2104/02/2202/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		11 648
11 343
2.69%		11 887
11 467
3.66%		11 218
11 180
0.34%		11 406
11 198
1.86%		11 337
11 498
-1.4%		11 226
11 811
-4.95%		10 966
10 959
0.06%		11 477
11 203
2.45%		11 865
11 451
3.62%
11 497


11 168


11 606


11 763


11 631

EBITDA
Million USD		Released
Forecast
Spread 		5 305
5 176
2.5%		7 812
5 060
54.38%		7 424
4 973
49.29%		4 288
4 594
-6.66%		5 030
4 732
6.3%		4 268
6 031
-29.24%		4 539
5 339
-14.98%		3 816
4 833
-21.04%		-8 984
-8 394
-7.03%
4 264


4 424


4 694







EBIT
Million USD		Released
Forecast
Spread 		5 267
4 848
8.63%		5 229
4 563
14.58%		4 836
4 622
4.62%		4 110
4 248
-3.26%		4 857
4 816
0.85%		4 251
4 785
-11.16%		4 360
4 206
3.66%		3 630
3 663
-0.91%		-8 329
-8 538
2.44%
4 149


4 044


4 184


4 906


4 630

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


1 958
2 118
-7.55%		2 209
2 139
3.27%		1 859
1 767
5.21%		2 770
2 808
-1.34%		1 859
2 836
-34.44%		2 137
2 216
-3.58%		1 674
2 000
-16.28%		-11 516



1 909


1 557


1 881







Net income
Million USD		Released
Forecast
Spread 		1 278


1 421
1 423
-0.11%		1 606
1 469
9.33%		2 022
1 444
40.03%		2 262
2 290
-1.24%		2 073
2 165
-4.23%		1 928
1 585
21.63%		1 762
1 479
19.13%		-11 911
-10 359
-14.98%
1 390


1 336


2 563







EPS
USD		Released
Forecast
Spread 		0,59
0,86
-31.4%		0,66
0,58
13.79%		0,75
0,71
5.63%		0,95
0,73
31.03%		1,07
1,19
-10.08%		0,99
1,16
-14.88%		0,93
0,89
4.03%		0,87
0,72
20.52%		-5,89
-4,84
-21.65%
0,81


0,78


1,25


1,82


1,70

Announcement Date29/04/2227/07/2225/10/2202/02/2327/04/2327/07/2326/10/2302/02/2425/04/24-----

Upcoming sector events for Bristol-Myers Squibb Company

03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
16/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 11:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Bristol-Myers Squibb Company

13/06/2024 22:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 06:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 11:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 10:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 13:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00 FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 10:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
29/05/2024 09:44 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BMY Stock
  4. BRM Stock
  5. Calendar Bristol-Myers Squibb Company